|Project Title||Gastrointestinal Therapy Agents Use 2|
Tuesday, September 23, 2014
Summary table assessments of the incident and prevalent use of eleven gastrointestinal therapy agents, aprepitant, fosaprepitant dimeglumine, cimetidine, dexlansoprazole, dicyclomine HCL, lubiprostone, mesalamine, nizatidine, sucralfate, and lansoprazol. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table. Summary tables are precompiled stratified counts. Queries were executed in 8/19/2013. This report includes data from 16 Data Partners.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to firstname.lastname@example.org.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.
gastrointestinal therapy agent
2000 - 2012
Mini-Sentinel Distributed Database (MSDD)
- Vaccines, Blood & Biologics
- Devices and Radiologic Health